Extension Study to Evaluate IV CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus
Public ClinicalTrials.gov record NCT03281538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter, Extension Study to Evaluate the Long Term Safety of Intravenous CR845 in Hemodialysis Patients With Chronic Kidney Disease-Associated Pruritus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label multicenter, long-term extension safety study to evaluate the safety of IV CR845 administered after each dialysis session over a Treatment Period of up to 52 weeks.
Study identification
- NCT ID
- NCT03281538
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 288 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 13, 2017
- Primary completion
- Feb 10, 2020
- Completion
- Feb 10, 2020
- Last update posted
- Oct 13, 2021
2017 – 2020
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cara Therapeutics Study Site | Chula Vista | California | 91990 | — |
| Cara Therapeutics Study Site | El Centro | California | 92243 | — |
| Cara Therapeutics Study Site | Long Beach | California | 90813 | — |
| Cara Therapeutics Study Site | Northridge | California | 91324 | — |
| Cara Therapeutics Study Site | Denver | Colorado | 80230 | — |
| Cara Therapeutics Study Site | Hollywood | Florida | 33024 | — |
| Cara Therapeutics Study Site | Tampa | Florida | 33614 | — |
| Cara Therapeutics Study Site | Winter Park | Florida | 32789 | — |
| Cara Therapeutics Study Site | Albany | Georgia | 31701 | — |
| Cara Therapeutics Study Site | Augusta | Georgia | 30909 | — |
| Cara Therapeutics Study Site | Meridian | Idaho | 83642 | — |
| Cara Therapeutics Study Site | Springfield | Massachusetts | 01107 | — |
| Cara Therapeutics Study Site | Roseville | Michigan | 48066 | — |
| Cara Therapeutics Study Site | Kansas City | Missouri | 64131 | — |
| Cara Therapeutics Study Site | Albuquerque | New Mexico | 87109 | — |
| Cara Therapeutics Study Site | Gallup | New Mexico | 87301 | — |
| Cara Therapeutics Study Site | Mineola | New York | 11501 | — |
| Cara Therapeutics Study Site | Ridgewood | New York | 11385 | — |
| Cara Therapeutics Study Site | Bethlehem | Pennsylvania | 18017 | — |
| Cara Therapeutics Study Site | Knoxville | Tennessee | 37920 | — |
| Cara Therapeutics Study Site | El Paso | Texas | 79902 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78202 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78221 | — |
| Cara Therapeutics Study Site | San Antonio | Texas | 78229 | — |
| Cara Therapeutics Study Site | St. George | Utah | 84790 | — |
| Cara Therapeutics Study Site | Wauwatosa | Wisconsin | 53326 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03281538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2021 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03281538 live on ClinicalTrials.gov.